Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere are three licensed sites for Mounjaro injections: the abdomen, the thigh, and the upper arm. Each works because the subcutaneous fat layer at these locations absorbs tirzepatide reliably, and rotating between them helps your skin stay healthy over months of weekly treatment. Mounjaro is a prescription-only medicine; a prescriber assesses suitability before treatment begins, and your Patient Information Leaflet is the definitive reference for technique. That said, a lot of the worry people bring to this question comes from a misconception worth clearing up first.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Many people beginning Mounjaro treatment assume the abdomen is the 'best' injection site — perhaps because they've seen it depicted most often, or because it feels easiest to see and reach. The evidence behind the licensed guidance doesn't support that hierarchy. All three approved locations to inject Mounjaro are considered equivalent for absorption in healthy subcutaneous tissue, and the NHS patient guidance on tirzepatide confirms that the choice between abdomen, thigh, and upper arm is yours to make based on comfort and access.
What does matter, considerably, is not using the same spot week after week. Repeated injections into one small area can cause lipohypertrophy (the skin becomes thickened and irregular) and medicine absorbed through damaged tissue may not reach therapeutic levels consistently. Rotating your Mounjaro injection locations, within and between sites, is one of the simplest things you can do to protect your results over time. Think of it as a pattern rather than a preference: left thigh one week, right abdomen the next, upper arm the week after.
If you're new to Mounjaro injections and wondering about the basics of how the pen itself works, the step-by-step injection guide covers the full technique from cap to click.
The abdomen is the site most people find easiest to manage independently. Inject into the fatty tissue at least two inches away from your navel, avoid the ring of skin immediately around it. The lower and outer areas of the belly generally have more subcutaneous fat and tend to be comfortable. Avoid any area that is bruised, scarred, or affected by a skin condition.
The outer thigh is a practical alternative and works well for people who find abdominal injections uncomfortable. Use the outer, fleshy portion of the upper thigh rather than the inner thigh or the area close to the knee. Sitting down with the thigh relaxed makes the tissue more accessible. For more detail on this specific location, the Mounjaro thigh injection guide walks through positioning and common questions.
The upper arm is the least commonly self-administered site simply because it can be awkward to reach, many people ask a partner or carer to help with this one. If you do inject your arm yourself, the outer, fleshy area midway between the shoulder and elbow is the target zone. Pinching the skin gently first helps ensure you're in subcutaneous tissue rather than muscle.
Across all three sites, let an alcohol swab dry completely before inserting the needle, inserting into damp skin can sting and may compromise sterility. Medical-grade alcohol swabs are the standard choice.
Injection-site redness, mild swelling or brief tenderness after a Mounjaro injection are listed side effects and are generally short-lived. Rotating locations is the primary way to reduce their frequency. Beyond rotation, a few practical steps help: bring the pen to room temperature for a short time before injecting (your leaflet gives the exact window), inject slowly and steadily rather than pressing the button forcefully, and hold the pen in place until the injection is complete.
Persistent lumps, prolonged redness, or any sign of infection (spreading warmth, pus, fever) should prompt a call to your prescriber or GP rather than a wait-and-see approach. The MHRA Yellow Card scheme also allows you to report any unexpected side effects directly, which contributes to the ongoing safety monitoring of tirzepatide in the UK.
For a broader picture of how Mounjaro works as a treatment and what to expect week by week, this overview of Mounjaro injections puts the injection technique into wider context.
The Mounjaro KwikPen arrives through DPD in plain, unbranded packaging, nothing on the outside identifies the contents. Inside, the pen is pre-filled and pre-set: there's no dose to dial, no cartridge to load. Each pen contains four weekly doses, each delivered through a fine, short needle. Used needles are sharps and must be disposed of in a proper sharps container rather than household bins; if you don't already have one, a 1-litre sharps container is the standard size for home use. Your local council or pharmacy can tell you how to arrange collection once it's full.
Needle length is fixed on the KwikPen, but if you have questions about supplies, the Mounjaro pen page covers what comes with treatment. Cost considerations around ongoing private treatment are explained on the Mounjaro UK pricing page, which covers the context behind recent list-price changes.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.